Growing Usage of Feed Additive Medication Boost the Growth of Poultry Pharmaceuticals Market: The Market is expected to reach US$7.8 Billion by 2024

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of poultry pharmaceuticals such as drugs, vaccines, and feed additive medication, as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global poultry pharmaceuticals market with respect to the leading market segments based on major pharmaceutical products, animal types, and geographies. The poultry pharmaceuticals market has been studied based on major product segments and their regional as well as national markets. Based on product type, the global market has been categorized into three major segments: drugs, vaccines, and feed additive medication. Based on animal type, the global market has been categorized into five major segments: chicken, turkey, duck, goose, and others (emus, etc.). The market for these segments has been extensively analyzed based on their utility, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

Inquire for Sample Copy of Report - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11486

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the poultry pharmaceuticals market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. Geographically, the poultry pharmaceuticals market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each regional market for poultry pharmaceuticals has been further categorized into major national markets such as the U.S, Canada, Germany, the U.K., India, China, and Brazil. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

The report also profiles key players operating in the poultry pharmaceuticals market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, and Zoetis, Inc.

Table of Content - Some Key Points

5. Market Dynamics
5.1. Market Drivers
5.1.1. Greater Emphasis On Prevention And Wellness By Veterinarians And Owners
5.1.2. Increased Consumption of Animal Protein Among Human Population
5.1.3. Increased Epidemic of Poultry Diseases
5.1.4. Demand of meat and protein source
5.1.5. Evolution of Epizootic Avian Flu
5.1.6. Increasing Poultry Franchise Among Emerging Regions
5.1.7. Government And Private Initiatives for Vaccination Program Among Poultry Farms
5.1.2. Restraints
5.1.2.1. Stringent Regulations
5.1.2.2. High Medical Costs
5.1.2.3. Rising Concern About the Use of Antibiotics and Growth Promoters in Food Animals
5.1.3. Opportunities
5.1.3.1. Technological Development and Innovation
5.1.3.2. Significant Scope in Emerging Markets
5.2. Porter’s Five Forces Analysis
5.3. Value Chain Analysis
5.4. Poultry Pharmaceuticals Market Outlook

6. Poultry Pharmaceuticals Market Analysis, by Product Type
6.1. Introduction
6.2. Key Findings
6.3. Global Poultry Pharmaceuticals Market Value Share Analysis, by Product Type
6.3.1. Drugs
6.3.1.1. VETRIMOXIN
6.3.1.2. Other Drug Products
6.3.2. Vaccines
6.3.2.1. INNOVAX
6.3.2.2. NOBILIS
6.3.2.3. Poulvac
6.3.2.4. Other Vaccine Products
6.3.3. Feed Additive Medication
6.3.3.1. VIGOSINE
6.3.3.2. Amnovit
6.3.3.3. Other Feed Additive Medication
6.4. Key Trends
6.5. Poultry Pharmaceuticals Market Attractiveness Analysis, by Product Type

7. Global Poultry Pharmaceuticals Market Analysis, by Animal Type
7.1. Introduction
7.2. Key Findings
7.3. Global Poultry Pharmaceuticals Market Analysis, by Animal Type
7.3.1. Chicken
7.3.2. Turkey
7.3.3. Duck
7.3.4. Goose
7.3.5. Others
7.4. Poultry Pharmaceuticals Market Attractiveness Analysis, by Animal
7.5. Key Trends

8. Global Poultry Pharmaceuticals Market Value Share Analysis, by Region
8.1. Global Market Scenario
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Latin America
8.6. Middle East and Africa

Read Press Release - http://www.transparencymarketresearch.com/pressrelease/poultry-pharmaceuticals-market.htm

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.